University Technical College, Cambridge, encourages its students to consider working in the biotechnology sector in a collaboration with MedImmune.
University Technical College, Cambridge, UK, has joined with US-based biotechnology company MedImmune in launching a six-week “Challenge Project” aimed at UK students in Year 10.
MedImmune is the global biologics research and development arm of UK-based pharmaceutical company AstraZeneca.
Sixty Year Ten students, aged around 14 to 16, will have the opportunity to spend one day a week with scientists from MedImmune’s Cambridge site learning about aspects of the company. This will range from drug development, regulation, manufacturing and pricing.
…
